相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
Tianyu Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Enzymatic Tagging of Glycoproteins on the Cell Surface for Their Global and Site-Specific Analysis with Mass Spectrometry
Fangxu Sun et al.
ANALYTICAL CHEMISTRY (2019)
Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome
Gemma White et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre-Clinical Detection of Off-Target Toxicities Associated with Sunitinib Malate
Alice C. O'Farrell et al.
PROTEOMICS CLINICAL APPLICATIONS (2019)
An Integrative Analysis of Tumor Proteomic and Phosphoproteomic Profiles to Examine the Relationships Between Kinase Activity and Phosphorylation
Osama A. Arshad et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Activity-Based Protein Profiling Identifies α-Ketoamides as Inhibitors for Phospholipase A2 Group XVI
Juan Zhou et al.
ACS CHEMICAL BIOLOGY (2019)
Diversity-oriented synthesis of bicyclic fragments containing privileged azines
Nicola Luise et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Plasma metabolites associated with colorectal cancer: A discovery-replication strategy
Anne J. M. R. Geijsen et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry
Dong Wang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
Sebastian Scheer et al.
NATURE COMMUNICATIONS (2019)
A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer
Hengchao Li et al.
CANCER GENOMICS & PROTEOMICS (2019)
Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-α4β7 integrin antibody
Sijia He et al.
SCIENCE ADVANCES (2019)
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Chemoproteonnics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target
Jessica L. Counihan et al.
ACS CHEMICAL BIOLOGY (2018)
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit
Hui Qiu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
On the glycosylation aspects of biosimilarity
Laszlo Hajba et al.
DRUG DISCOVERY TODAY (2018)
Hot-spot analysis for drug discovery targeting protein-protein interactions
Mireia Rosell et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Metal-Binding Isosteres as New Scaffolds for Metalloenzyme Inhibitors
Benjamin L. Dick et al.
INORGANIC CHEMISTRY (2018)
Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product
Kyoung Hoon Lee et al.
MABS (2018)
Chemoproteomics Reveals the Antiproliferative Potential of Parkinson's Disease Kinase Inhibitor LRRK2-IN-1 by Targeting PCNA Protein
Weichao Li et al.
MOLECULAR PHARMACEUTICS (2018)
How many human proteoforms are there?
Ruedi Aebersold et al.
NATURE CHEMICAL BIOLOGY (2018)
Recent advances in mass spectrometry-based approaches for proteomics and biologics: Great contribution for developing therapeutic antibodies
Noriko Iwamoto et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Chemoproteomics and Chemical Probes for Target Discovery
Gerard Drewes et al.
TRENDS IN BIOTECHNOLOGY (2018)
Systematic quantitative analysis of H2A and H2B variants by targeted proteomics
Sara El Kennani et al.
EPIGENETICS & CHROMATIN (2018)
The development of piperidinones as potent MDM2-P53 protein - protein interaction inhibitors for cancer therapy
Guochao Liao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Constrained peptides' time to shine?
Chris Morrison
NATURE REVIEWS DRUG DISCOVERY (2018)
Launching the C-HPP neXt-CP50 Pilot Project for Functional Characterization of Identified Proteins with No Known Function
Young-Ki Paik et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Dark Proteins Important for Cellular Function
Andrea Schafferhans et al.
PROTEOMICS (2018)
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
Kristina B. Emdal et al.
SCIENCE SIGNALING (2018)
Biosimilars in ophthalmology: Is there a big change on the horizon?
Ashish Sharma et al.
CLINICAL OPHTHALMOLOGY (2018)
Analytical characterization of recombinant hCG and comparative studies with reference product
Rajamannar Thennati et al.
BIOLOGICS-TARGETS & THERAPY (2018)
Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathway
Justin B. Davis et al.
HELIYON (2018)
Prediction of Protein Hotspots from Whole Protein Sequences by a Random Projection Ensemble System
Jinjian Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Veronica Tisato et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Multiplexed Phosphoproteomic Profiling Using Titanium Dioxide and Immunoaffinity Enrichments Reveals Complementary Phosphorylation Events
Anthony P. Possemato et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Constrained Peptides in Drug Discovery and Development
Douglas R. Cary et al.
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN (2017)
Polypharmacology-based ceritinib repurposing using integrated functional proteomics
Brent M. Kuenzi et al.
NATURE CHEMICAL BIOLOGY (2017)
Oxetanyl Amino Acids for Peptidomimetics
Guido P. Moller et al.
ORGANIC LETTERS (2017)
Quantitative proteomics of breast tumors: Tissue quality assessment to clinical biomarkers
Yi Chen et al.
PROTEOMICS (2017)
Sample Clean-up Strategies for ESI Mass Spectrometry Applications in Bottom-up Proteomics: Trends from 2012 to 2016
Ria Marni Tubaon et al.
PROTEOMICS (2017)
Click chemistry enables preclinical evaluation of targeted epigenetic therapies
Dean S. Tyler et al.
SCIENCE (2017)
Cell-Penetrating Peptides: From Basic Research to Clinics
Giulia Guidotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
Shawn T. Beug et al.
NATURE COMMUNICATIONS (2017)
Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulations
Qianqian Wang et al.
SCIENTIFIC REPORTS (2017)
Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools
Naiem T. Issa et al.
CURRENT DRUG METABOLISM (2017)
Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of WT p53 in patients with solid tumors and lymphomas.
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array
Marina Portolino et al.
CELL DEATH DISCOVERY (2017)
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial
Denise M. Wolf et al.
NPJ BREAST CANCER (2017)
Orally Absorbed Cyclic Peptides
Daniel S. Nielsen et al.
CHEMICAL REVIEWS (2017)
Naturally Inspired Peptide Leads: Alanine Scanning Reveals an Actin-Targeting Thiazole Analogue of Bisebromoamide
Heather J. Johnston et al.
CHEMBIOCHEM (2016)
Targeting protein-protein interactions, a wide open field for drug design
May Bakail et al.
COMPTES RENDUS CHIMIE (2016)
Finding Our Way in the Dark Proteome
Asmit Bhowmick et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Six alternative proteases for mass spectrometry-based proteomics beyond trypsin
Piero Giansanti et al.
NATURE PROTOCOLS (2016)
Pioneering apoptosis-targeted cancer drug poised for FDA approval
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2016)
Advances in targeted proteomics and applications to biomedical research
Tujin Shi et al.
PROTEOMICS (2016)
Parallel reaction monitoring using quadrupole-Orbitrap mass spectrometer: Principle and applications
Adele Bourmaud et al.
PROTEOMICS (2016)
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
Abdul Muheem et al.
SAUDI PHARMACEUTICAL JOURNAL (2016)
Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Ju Yeon Lee et al.
NATURE COMMUNICATIONS (2016)
Promises and Challenges of Smac Mimetics as Cancer Therapeutics
Simone Fulda
CLINICAL CANCER RESEARCH (2015)
Unlocking the secrets to protein-protein interface drug targets using structural mass spectrometry techniques
Angela Dailing et al.
EXPERT REVIEW OF PROTEOMICS (2015)
Proteomics beyond trypsin
Liana Tsiatsiani et al.
FEBS JOURNAL (2015)
Unexpected features of the dark proteome
Nelson Perdigao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
Krzysztof M. Zak et al.
STRUCTURE (2015)
T-cell exhaustion in the tumor microenvironment
Y. Jiang et al.
CELL DEATH & DISEASE (2015)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
Yujun Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
PEG-Peptide Conjugates
Ian W. Hamley
BIOMACROMOLECULES (2014)
Glioblastoma Cell Enrichment Is Critical for Analysis of Phosphorylated Drug Targets and Proteomic-Genomic Correlations
Claudius Mueller et al.
CANCER RESEARCH (2014)
Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report
Rehan Akbani et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Reverse Phase Protein Arrays: Mapping the Path Towards Personalized Medicine
Rosa I. Gallagher et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
Reverse-Phase Protein Array for Prediction of Patients at Low Risk of Developing Bone Metastasis From Breast Cancer
Naoki Hayashi et al.
ONCOLOGIST (2014)
Small-molecule SMAC mimetics as new cancer therapeutics
Longchuan Bai et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Protein painting reveals solvent-excluded drug targets hidden within native protein-protein interfaces
Alessandra Luchini et al.
NATURE COMMUNICATIONS (2014)
A pan-cancer proteomic perspective on The Cancer Genome Atlas
Rehan Akbani et al.
NATURE COMMUNICATIONS (2014)
The Use of Antibodies in Small-Molecule Drug Discovery
Catherine J. Marsden et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Quantitative Assessment of In-solution Digestion Efficiency Identifies Optimal Protocols for Unbiased Protein Analysis
Ileana R. Leon et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Effective Identification of Akt Interacting Proteins by Two-Step Chemical Crosslinking, Co-Immunoprecipitation and Mass Spectrometry
Bill X. Huang et al.
PLOS ONE (2013)
A Strategy for Large-Scale Phosphoproteomics and SRM-Based Validation of Human Breast Cancer Tissue Samples
Ryohei Narumi et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics
Amelia C. Peterson et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
P. N. Kelly et al.
CELL DEATH AND DIFFERENTIATION (2011)
Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
Bonsu Ku et al.
CELL RESEARCH (2011)
Proteomics and biomarkers in clinical trials for drug development
Jung-min Lee et al.
JOURNAL OF PROTEOMICS (2011)
Reverse phase protein microarrays advance to use in clinical trials
Claudius Mueller et al.
MOLECULAR ONCOLOGY (2010)
Structural characterization of a β-turn mimic within a protein-protein interface
Bjoern Eckhardt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Finding one's way in proteomics: a protein species nomenclature
Hartmut Schlueter et al.
CHEMISTRY CENTRAL JOURNAL (2009)
NMR methods in fragment screening: theory and a comparison with other biophysical techniques
Claudio Dalvit
DRUG DISCOVERY TODAY (2009)
Concentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles
Claudia Fredolini et al.
NANO RESEARCH (2008)
Exploring the hidden human urinary proteome via ligand library beads
A Castagna et al.
JOURNAL OF PROTEOME RESEARCH (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Role of histone acetylation in the control of gene expression
L Verdone et al.
BIOCHEMISTRY AND CELL BIOLOGY (2005)
Protein microarrays: Meeting analytical challenges for clinical applications
LA Liotta et al.
CANCER CELL (2003)
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
CP Paweletz et al.
ONCOGENE (2001)
分享论文
